Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H11NO |
Molecular Weight | 137.179 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NCCC1=CC=C(O)C=C1
InChI
InChIKey=DZGWFCGJZKJUFP-UHFFFAOYSA-N
InChI=1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2
Molecular Formula | C8H11NO |
Molecular Weight | 137.179 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tyramine is a naturally occurring monoamine compound and trace amine derived from the amino acid tyrosine. Tyramine occurs widely in plants and animals, and is metabolized by the enzyme monoamine oxidase. Tyramine is an alpha-adrenergic agonist. Hypertension can occur, from ingestion of tyramine-rich foods in conjunction with monoamine oxidase inhibitors. The possibility that tyramine acts directly as a neurotransmitter was revealed by the discovery of a G protein-coupled receptor with high affinity for tyramine, called TAAR. It exhibits sympathomimetic effects by causing the release of endogenic norepinephrine. It has been used in mydriatic eyedrops. This has been said to reduce the intraocular pressure in rabbits and in some patients with open-angle glaucoma.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL5857 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27424325 |
0.2 µM [EC50] | ||
Target ID: Q9P1P5 Gene ID: 9287.0 Gene Symbol: TAAR2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27424325 |
0.52 nM [EC50] | ||
Target ID: P31513 Gene ID: 2328.0 Gene Symbol: FMO3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15922018 |
|||
Target ID: CHEMBL2095203 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16742159 |
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. | 1999 Dec |
|
Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells. | 1999 Jun 1 |
|
Why do some dietary migraine patients claim they get headaches from placebos? | 2000 May |
|
Mapping of the distribution of significant proteins and proteoglycans in small intestinal submucosa by fluorescence microscopy. | 2001 |
|
Quantification of tumour vascularity in squamous cell carcinoma of the tongue using CARD amplification, a systematic sampling technique, and true colour image analysis. | 2001 |
|
Synthesis of monensin derivatives and their effect on the activity of ricin A-chain immunotoxins. | 2001 |
|
Regulation of human monoamine oxidase B gene by Sp1 and Sp3. | 2001 Apr |
|
Involvement of noradrenaline transporters in S-nitrosocysteine-stimulated noradrenaline release from rat brain slices: existence of functional Na(+)-independent transporter activity. | 2001 Apr |
|
Following the trace of elusive amines. | 2001 Aug 14 |
|
Functional expression of a locust tyramine receptor in murine erythroleukaemia cells. | 2001 Dec |
|
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. | 2001 Dec |
|
Biochemical and kinetic analysis of the RNase active sites of the integrase/tyrosine family site-specific DNA recombinases. | 2001 Dec 7 |
|
Octopamine influences division of labor in honey bee colonies. | 2001 Feb |
|
Biogenic amines in vacuum-packaged and carbon dioxide-controlled atmosphere-packaged fresh pork stored at -1.50 degrees C. | 2001 Feb |
|
An in situ hybridization protocol to detect rare mRNA expressed in neural tissue using biotin-labelled oligonucleotide probes. | 2001 Feb |
|
Evidence for receptor-mediated hepatic uptake of pullulan in rats. | 2001 Feb 23 |
|
Effects of pH, temperature and NaCl concentration on the growth kinetics, proteolytic activity and biogenic amine production of Enterococcus faecalis. | 2001 Feb 28 |
|
Formation of nitric oxide from nitroxyl anion: role of quinones and ferricytochrome c. | 2001 Jan |
|
Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase. | 2001 Jan |
|
Dorsomedial medulla is more susceptible than rostral ventrolateral medulla to hypoxic insult in cats. | 2001 Jan |
|
The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. | 2001 Jan |
|
Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol. | 2001 Jan |
|
Formation of biogenic amines in bulk-stored chilled hake (Merluccius merluccius L.) packed under atmospheres. | 2001 Jul |
|
Reappearance of cardiac presynaptic sympathetic nerve terminals in the transplanted heart: correlation between PET using (11)C-hydroxyephedrine and invasively measured norepinephrine release. | 2001 Jul |
|
Trace amines: identification of a family of mammalian G protein-coupled receptors. | 2001 Jul 31 |
|
Detection of protein oxidation in endothelial cells by fluorescently labelled tyramine. | 2001 Jul-Aug |
|
Familial orthostatic tachycardia due to norepinephrine transporter deficiency. | 2001 Jun |
|
Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. | 2001 Jun |
|
Effect of P-glycoprotein modulators on the human extraneuronal monoamine transporter. | 2001 Jun 22 |
|
Neuroendocrine differentiation in bronchial carcinomas of classic squamous-cell type: an immunohistochemical study of 29 cases applying the tyramide signal amplification technique. | 2001 Mar |
|
In situ hybridization detection of calcitonin mRNA in routinely fixed, paraffin-embedded tissue sections: a comparison of different types of probes combined with tyramide signal amplification. | 2001 Mar |
|
Effectiveness of a Lactobacillus sakei starter culture in the reduction of biogenic amine accumulation as a function of the raw material quality. | 2001 Mar |
|
The pancreas-specific protein disulphide-isomerase PDIp interacts with a hydroxyaryl group in ligands. | 2001 Mar 15 |
|
Synthesis and characterization of immobilized dopamine beta-hydroxylase in membrane-bound and solubilized formats. | 2001 Mar 28 |
|
Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine. | 2001 May |
|
Substituent-dependent, positive and negative modulation of Bombyx mori adenylate cyclase by synthetic octopamine/tyramine analogues. | 2001 May |
|
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. | 2001 May |
|
[New development of hair examination! The searching of hair for the terminal residual substance of pleasant sensation]. | 2001 Nov |
|
Apical dominance in Pssu-ipt-transformed tobacco. | 2001 Nov |
|
Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. | 2002 Apr |
|
Applications of enzymatic amplification staining in immunophenotyping hematopoietic cells. | 2002 Apr 1 |
|
Tyrosine residues near the FAD binding site are critical for FAD binding and for the maintenance of the stable and active conformation of rat monoamine oxidase A. | 2002 Jan |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7356898
1.25 ug, 4.75 ug, 12.5 ug, 47.5 ug, 125 ug, and 475 ug twice weekly with a minimum of 48 h between doses. The six doses were given in ascending order.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12438548
In rat cardiomyocytes, 0.3 mM tyramine activated 2-deoxyglucose uptake to around 40% of the maximal insulin effect and benzylamine had no effect. Concentration-dependent studies showed that the EC50 of tyramine in activating hexose uptake was 10 uM in cardiomyocytes, whereas in the presence of vanadate, the EC50 of tyramine was 117 uM in adipocytes.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:09 GMT 2023
by
admin
on
Fri Dec 15 15:12:09 GMT 2023
|
Record UNII |
X8ZC7V0OX3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
3158 (Number of products:17)
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB15650MIG
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
15760
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
100000077310
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
51-67-2
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
TYRAMINE
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
m11286
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
200-115-8
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
10958
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | RxNorm | ||
|
5610
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
327995
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
DTXSID2043874
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
249188
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
2784
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
1580
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
D014439
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
2132
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
X8ZC7V0OX3
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
X8ZC7V0OX3
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY | |||
|
DB08841
Created by
admin on Fri Dec 15 15:12:10 GMT 2023 , Edited by admin on Fri Dec 15 15:12:10 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PARENT |
MINOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
limits for Ractopamine Hydrochloride Suspension
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|